Thursday, August 24, 2006

Suggested Plan-B Warning Label

Unfortunately, my heroic President has done something abysmal. He has allowed that horrific Plan-B pill to go on sale over the counter. Now women can make sure they kill their children right away so they can spare themselves the embarrassment of even telling an abortion doctor they were naughty. Amazing how this is a "medical" issue, even though it carries with it a shame unheard of when taking Tylenol. But even Tylenol has a warning label....

Plan-B suggested warning label (by me):

Warning: Pregnant, possibly pregnant, or nursing women should not take this drug do to complications that may arise. Consult your doctor before using if you are sexually active to reduce the risk of injury or death to your fetus.

Here's the story from CWNews in case you missed it...

"Morning-after" pill cleared for sale in US

Washington, Aug. 24 ( - The US Food and Drug Administration (FDA) has authorized over-the-counter sale of the "morning-after" pill, with the proviso that non-prescription sales of the drug known as "Plan B" will be limited to consumers over the age of 18.

The FDA decision, coming after months of heated debate, is a severe setback for pro-life activists in Washington. Judie Brown, president of American Life League, remarked that she was "overwhelmingly disappointed" with the announcement.

"Even more troubling," Brown observed, "is the fact that President Bush most likely helped to speed this approval with his recent comments suggesting that prescription sales were only necessary for women under 18." At an August 21 press conference the President had said that Plan B "ought to require a prescription for minors."

“Let there be no mistake about it," said Father Thomas Euteneuer, the president of Human Life International; "today’s decision lies at the feet of President Bush and has created a lasting rift with the Catholic faithful who compromise a large part of his support base. His statements at this past Monday’s press conference in support of over-the-counter sales set the stage for this morning's decision."

A year ago, the FDA had declined to authorized non-prescription sale of the abortifacient drug, in spite of heavy political pressure. But in late July, the President's new nominee as FDA commissioner, Dr. Andrew von Eschenbach, announced that the decision was under review. That announcement-- which came the day before the FDA nominee was due to face Senate confirmation hearings-- led to a general expectation that the FDA would authorize over-the-counter sales.

No comments:

"The whole truth is generally the ally of virtue; a half-truth is always the ally of some vice." - G.K. Chesterton